N-heterocyclic compounds that block cytokine production via inhibition
of p38 kinase are disclosed. In one embodiment, compounds of the present invention
are represented by Formula I:
##STR1##
Methods of production, pharmaceutical compositions and methods of treating
conditions associated with inappropriate p38 kinase activity or TNF- expression
utilizing compounds of the present invention are also disclosed.
